Linzess 145 MCG capsule UU 30S
Ended Awarded
- Contract number
- SPE2DB25FJPE3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,141
Award facts
- Contract value 100% obligated
- $3,141.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,141.04 to AmerisourceBergen Drug Corp for 30 capsules of LINZESS 145 MCG, a prescription medication used to treat chronic idiopathic constipation and irritable bowel syndrome with constipation. This firm fixed-price delivery order, awarded on June 27, 2025, with an ultimate completion date of June 30, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order falls under the company's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX, running through December 2026), which enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The DLA Troop Support Medical supply chain relies on AmerisourceBergen's extensive pharmaceutical portfolio to deliver specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FJPE3?
SPE2DB25FJPE3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 27, 2025.
How much is contract SPE2DB25FJPE3 worth?
The government has obligated $3,141 on SPE2DB25FJPE3.
Is contract SPE2DB25FJPE3 an order under another contract?
Yes. SPE2DB25FJPE3 is a delivery order under SPE2DB22D2005, an indefinite delivery contract.
Was contract SPE2DB25FJPE3 competed?
The extent of competition for SPE2DB25FJPE3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award